#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma malignant Angiosarcoma non-metastatic Sarcoma B precursor type acute leukaemia Ductal adenocarcinoma of pancreas Gastroenteropancreatic neuroendocrine tumour disease Thrombocytosis Rhabdomyosarcoma Extraskeletal ossification Neuroendocrine cell hyperplasia of infancy Burkitt's lymphoma Spinal muscular atrophy Antiphospholipid antibodies Familial dilated cardiomyopathy Anal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Brain stem glioma – Life with Disease Systemic mastocytosis – Diagnostics Advanced systemic mastocytosis – Basic Information Biotinidase deficiency – Treatment Glomerulonephritis rapidly progressive – Diagnostics Rhabdomyosarcoma – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Congenital hypotransferrinaemia – Diagnostics Kearns-Sayre syndrome Testicular leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cebsulfase Alfa Litifilimab Pentosan Polysulfate Sodium Histidine Piperacillin Sodium Venlafaxine Hydrochloride Mosunetuzumab Elasomeran Paliperidone Rebisufligene Etisparvovec Alxn1850 Ampreloxetine HYPOCHLOROUS ACID Sodium Azd8421 Raltegravir Urokinase Tipiracil Leniolisib Phosphate Leriglitazone More therapies…

    Learn about Your Condition

    Endocarditis bacterial Colitis Urticaria cholinergic Developmental hip dysplasia Polymyalgia rheumatica Bacterial infection Influenza Glucose tolerance impaired Hyperparathyroidism primary Alcohol abuse Diffuse large B-cell lymphoma Venous thrombosis Fibromyalgia Toxic nodular goitre Henoch-Schonlein purpura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiovascular disorder

  • A study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    • Spironolactone
    The Netherlands

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Hypertension
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Carbasalate Calcium
    • Colchicine
    Denmark Finland France Greece Italy Portugal

  • Study Comparing Buckberg and Del Nido Solutions for Heart Surgery in Patients with Cardiovascular Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Calcium Chloride
    • Magnesium Chloride
    • Potassium Chloride
    Spain

  • Study on Esmolol for Heart Issues in Patients with Cirrhosis, Diabetes, or Cardiotoxic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Esmolol Hydrochloride
    Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!